5Roussos A, Tsimpoukas F, Anastasakou E, et al. Helieobacter pylori seroprevalence in patients with chronic bronchitis [ J ]. J Gastroenterol, 2002 ;37:332-5.
6Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity [ J]. Chest,2002 ; 121 : 121-6.
7Gencer M, Ceylan E, Zeyrek FY, et al. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests[J]. Respiration ,2007 ;74 : 170-5.
8National Heart, Lung, and Blood Institute. Global initiative for chronic obstructive lung disease (GOLD): global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [ S]. Bethesda National Institutes of Health, 2004 : 1-112.
9Fedorova TA, Spirina L, Chernekhovskaia NE, et al. The stomach and duodenum condition in patients with chronic obstructive lung diseases [J]. KlinMed (Mosk) 2003;81:31-3.
10SUK KT,KIM HS,KIM MY,et al.In vitro antibacterial and morphological effects of the urushiol component of the sap of the korean lacquer tree (rhus vernicifera stokes) on helicobacter pylori[J].J Korean Med Sci,2010,25(3):399-404.
